A new blood test could help doctors identify whether a treatment for advanced prostate cancer treatment is failing weeks earlier than current tests, according to a UK-wide study led by UCL researchers. The study, published in Nature Cancer , shows that men could switch or intensify treatment much sooner than is currently possible if their cancer is not responding to treatment, potentially saving precious time and improving outcomes for patients. Researchers found that detecting tiny fragments